|
Journal of Clinical Oncology, ASCO Annual Meeting Proceedings (Post-Meeting Edition).
Vol , No 18S ( Supplement), :
© 2009 American Society of Clinical Oncology
Multivariate Analyses
|
Overall Survival
|
|
| Adjustment Variables |
Adjusted HR (CI) |
p-value |
| Treatment (Gem vs. 5-FU) |
1.23 (0.97,1.54) |
0.08 |
|
CA 19–9
|
<180 vs.  180 |
3.58 (2.40, 5.34) |
<0.0001 |
| <180 vs. Lewis Antigen Negative |
1.12 (0.87, 1.44) |
0.37 |
| Nodal Involvement (no vs. yes) |
1.46 (1.13, 1.89) |
0.004 |
| Tumor Diameter (<3 vs. 3cm) |
1.07 (0.83, 163) |
0.60 |
|
Surgical Margin Status
|
| Negative vs. Positive |
1.24 (0.94, 1.63) |
0.13 |
| Negative vs. Unknown |
0.96 (0.71, 1.30) |
0.78 |
|
|
